Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
40 participants
INTERVENTIONAL
2026-01-31
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of a Soy-based Meal Replacement Weight Loss Intervention to Impact Ectopic Fat
NCT01298817
The Effects of Beta-glucan Enriched Oatcake Consumption on Metabolic Disease Risk Factors
NCT02615444
High Fiber Rye Foods for Weight and Body Fat Reduction
NCT03097237
Acceptability of Dietary Fibre-based Foods
NCT03477981
Influence of Dietary Fiber-rich Meals on Gene Expression and Postprandial Glucose and Lipid Response
NCT01005342
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FibreGum Intervention Group
Participants chew one fiber-containing gum (FibreGum) three times daily (morning, noon, and evening) for at least 20 minutes each, over two months, with the option to extend the intervention to three months.
FibreGum chewing gum
Chewing gum containing galactooligosaccharides (GOS), delivering a total daily dose of 3 g of dietary fiber.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FibreGum chewing gum
Chewing gum containing galactooligosaccharides (GOS), delivering a total daily dose of 3 g of dietary fiber.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy adults aged 18 to 65 years (inclusive), as determined by the investigator
* BMI of 23 to 40 kg/m2 (inclusive)
* Living in Switzerland
* Ability and willingness to follow the study protocol (e.g., cognitive capacity for compliance, gum chewing)
* Access and willingness to use an electronic device (e.g., mobile phone, computer or tablet)
* Access to a scale to self-report weight
Exclusion Criteria
* Treatment with a GLP-1 agonist within the past 2 months
* Initiation/Discontinuation of nicotine product use (\>1 nicotine product per day, e.g., (e-)cigarette, gum) within the last 2 months (at investigator's discretion)
* Significant change in medication within the last 2 months (at investigator's discretion)
* Unable to chew gum 3 times daily (e.g. due to dental issues, at investigator's discretion)
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Bern
OTHER
DCB Research AG
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maria L Balmer, Prof. med.
Role: PRINCIPAL_INVESTIGATOR
Department of Biomedical Research, University of Bern
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Biomedical Research, University of Bern
Bern, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FaibaLite
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.